AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.445
  • -0.070-13.59%
20min DelayNot Open Dec 11 16:00 AET
155.50MMarket Cap-2.23P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Paradigm Biopharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/FY65.800K / 0.000--
--2023/FY46.760K / 5.000K--
--2022/FY79.220K / ----
--2021/FY8.942M / 3.400M--
--2020/FY4.695M / 2.625M--
DatePeriodRevenue/EstimateEarnings Call
--2024/FY65.800K / 0.000--
--2023/FY46.760K / 5.000K--
--2022/FY79.220K / ----
--2021/FY8.942M / 3.400M--
--2020/FY4.695M / 2.625M--

Unlock Free Earnings Estimates

Paradigm Biopharmaceuticals Ltd Earnings Reports

  • Paradigm Biopharmaceuticals Ltd: Appendix 4E and 2024 Annual Report

    Aug 29 20:53 ET

  • Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

    Feb 27 20:15 ET

  • Paradigm Biopharmaceuticals Ltd: 2023 Annual Report and Appendix 4E

    Aug 25, 2023 01:53 ET

  • Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

    Feb 26, 2023 17:57 ET

    • Read more

    Trending AU Stocks
    ASX High Dividend ASX High Dividend
    Symbol Mini Chart % Chg
    BHP Group Ltd
    BHP
    +0.41%
    CommBank
    CBA
    -0.07%
    National Australia Bank Ltd
    NAB
    -0.13%
    Telstra Group Ltd
    TLS
    -0.25%
    Westpac Banking Corp
    WBC
    -0.37%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 29, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data